HAS2 and pulmonary fibrosis: Conditional deletion of HAS2 in mesenchymal cells in α-smooth muscle actin (α-SMA)-HAS2 transgenic mice abrogated the invasive fibroblast phenotype, impeded myofibroblast accumulation, and inhibited the development of lung fibrosis [83].